Abstract: The present disclosure provides a method for measuring an underfill profile of an underfill material in an underfill cavity having a plurality of solder bumps. The method includes the operations of: determining a mesh having a plurality of elements according to the underfill cavity; calculating a reference force according to the underfill cavity; obtaining a driving force and a flow speed of the underfill material according to a plurality of weighting factors and the reference force, wherein the plurality of weighting factors respectively correspond to the plurality of elements; obtaining a plurality of volume fractions respectively corresponding to the plurality of elements according to the flow speed; and obtaining the underfill profile according to the plurality of volume fractions.

Abstract: A method of manufacturing a semiconductor device including operations of forming a first hard mask over an underlying layer on a substrate by a photolithographic and etching method, forming a sidewall spacer pattern having a first sidewall portion and a second sidewall portion on opposing sides of the first hard mask, etching the first sidewall portion, etching the first hard mask and leaving the second sidewall portion bridging a gap of the etched first hard mask, and processing the underlying layer using the second hard mask.

Abstract: The invention provides a chimeric receptor comprising NKG2D, DAP10 and CD3 zeta. Also disclosed is a composition comprising this chimeric receptor and methods for making and using it to enhance the cytotoxicity and antitumor capacity of NK cells. The invention also encompansses methods for use of NKG2D-DAP10-CD3 zeta polypeptides, vectors and cells in methods for treating cancer and other proliferative disorders, as well as infectious diseases.

Abstract: The invention provides a chimeric receptor comprising NKG2D, DAP10 and CD3 zeta. Also disclosed is a composition comprising this chimeric receptor and methods for making and using it to enhance the cytotoxicity and antitumor capacity of NK cells. The invention also encompasses methods for use of NKG2D-DAP10-CD3 zeta polypeptides, vectors and cells in methods for treating cancer and other proliferative disorders, as well as infectious diseases.

Abstract: The invention provides a chimeric receptor comprising NKG2D, DAP10 and CD3 zeta. Also disclosed is a composition comprising this chimeric receptor and methods for making and using it to enhance the cytotoxicity and antitumor capacity of NK cells. The invention also encompasses methods for use of NKG2D-DAP10-CD3 zeta polypeptides, vectors and cells in methods for treating cancer and other proliferative disorders, as well as infectious diseases.

Abstract: The invention provides a chimeric receptor comprising NKG2D, DAP10 and CD3 zeta. Also disclosed is a composition comprising this chimeric receptor and methods for making and using it to enhance the cytotoxicity and antitumor capacity of NK cells. The invention also encompasses methods for use of NKG2D-DAP10-CD3 zeta polypeptides, vectors and cells in methods for treating cancer and other proliferative disorders, as well as infectious diseases.

Abstract: A wireless device includes a first transceiver circuit, a power splitter, a first directional antenna, and a second directional antenna. The first directional antenna is connected to a second end of the power splitter and has a first feeding portion and a first radiation unit, and the first feeding portion has a first line length. The second directional antenna is connected to a third end of the power splitter and has a second feeding portion and a second radiation unit, and the second feeding portion has a second line length. A phase difference is provided between the first directional antenna and the second directional antenna. The first transceiver circuit forms, through the first directional antenna, the second directional antenna and the predetermined phase difference, a predetermined pattern to transmit or receive signals, and the predetermined pattern has omnidirectionality.

Abstract: A wireless device includes a first transceiver circuit, a power splitter, a first directional antenna, and a second directional antenna. The first directional antenna is connected to a second end of the power splitter and has a first feeding portion and a first radiation unit, and the first feeding portion has a first line length. The second directional antenna is connected to a third end of the power splitter and has a second feeding portion and a second radiation unit, and the second feeding portion has a second line length. A phase difference is provided between the first directional antenna and the second directional antenna. The first transceiver circuit forms, through the first directional antenna, the second directional antenna and the predetermined phase difference, a predetermined pattern to transmit or receive signals, and the predetermined pattern has omnidirectionality.

Abstract: The invention provides a chimeric receptor comprising NKG2D, DAP10 and CD3 zeta. Also disclosed is a composition comprising this chimeric receptor and methods for making and using it to enhance the cytotoxicity and antitumor capacity of NK cells. The invention also encompasses methods for use of NKG2D-DAP10-CD3 zeta polypeptides, vectors and cells in methods for treating cancer and other proliferative disorders, as well as infectious diseases.

Abstract: A clock generation circuit arranged in a first system is disclosed. The clock generation circuit includes: a first dual-mode PLL, arranged for generating a first output clock in an integer-N mode or a fractional-N mode selectively, the first output clock being generated based on a first reference clock; and a second dual-mode PLL, arranged for generating a second output clock in an integer-N mode or a fractional-N mode selectively, the second output clock being generated based on the first output clock or a second reference clock selectively. Associated circuitries are also disclosed.

Abstract: The invention provides a chimeric receptor comprising NKG2D, DAP10 and CD3 zeta. Also disclosed is a composition comprising this chimeric receptor and methods for making and using it to enhance the cytotoxicity and antitumor capacity of NK cells. The invention also encompansses methods for use of NKG2D-DAP10-CD3 zeta polypeptides, vectors and cells in methods for treating cancer and other proliferative disorders, as well as infectious diseases.

Abstract: A clock generation circuit arranged in a first system is disclosed. The clock generation circuit includes: a first dual-mode PLL, arranged for generating a first output clock in an integer-N mode or a fractional-N mode selectively, the first output clock being generated based on a first reference clock; and a second dual-mode PLL, arranged for generating a second output clock in an integer-N mode or a fractional-N mode selectively, the second output clock being generated based on the first output clock or a second reference clock selectively. Associated circuitries are also disclosed.

Abstract: A method for constructing a database of Wi-Fi beacon locations is provided. The method includes: storing raw observation data for Wi-Fi beacons in the database of Wi-Fi beacon locations; (b) generating observation data records for the Wi-Fi beacons according to the raw observation data, and computing a rough location estimate for each Wi-Fi beacon according to the observation data records; (c) finding outliers of each Wi-Fi beacon from the rough location estimate and the observation data records; (d) excluding the outliers from the observation data records, and computing final location estimates for the Wi-Fi beacons according to the observation data records which do not include the outliers; (e) computing inferred-location estimates for the Wi-Fi beacons which do not have a location fix according to the final location estimates; and (f) storing the inferred-location estimates in the beacon location database.

Abstract: The invention provides a chimeric receptor comprising NKG2D, DAP10 and CD3 zeta. Also disclosed is a composition comprising this chimeric receptor and methods for making and using it to enhance the cytotoxicity and antitumor capacity of NK cells. The invention also encompasses methods for use of NKG2D-DAP10-CD3 zeta polypeptides, vectors and cells in methods for treating cancer and other proliferative disorders, as well as infectious diseases.

Abstract: The invention provides a chimeric receptor comprising NKG2D, DAP10 and CD3 zeta. Also disclosed is a composition comprising this chimeric receptor and methods for making and using it to enhance the cytotoxicity and antitumor capacity of NK cells. The invention also encompasses methods for use of NKG2D-DAP10-CD3 zeta polypeptides, vectors and cells in methods for treating cancer and other proliferative disorders, as well as infectious diseases.

Abstract: The invention provides a chimeric receptor comprising NKG2D, DAP10 and CD3 zeta. Also disclosed is a composition comprising this chimeric receptor and methods for making and using it to enhance the cytotoxicity and antitumor capacity of NK cells. The invention also encompasses methods for use of NKG2D-DAP10-CD3 zeta polypeptides, vectors and cells in methods for treating cancer and other proliferative disorders, as well as infectious diseases.

Abstract: The invention provides a chimeric receptor comprising NKG2D, DAP10 and CD3 zeta. Also disclosed is a composition comprising this chimeric receptor and methods for making and using it to enhance the cytotoxicity and antitumor capacity of NK cells. The invention also encompasses methods for use of NKG2D-DAP10-CD3 zeta polypeptides, vectors and cells in methods for treating cancer and other proliferative disorders, as well as infectious diseases.

Abstract: The invention provides a chimeric receptor comprising NKG2D, DAP10 and CD3 zeta. Also disclosed is a composition comprising this chimeric receptor and methods for making and using it to enhance the cytotoxicity and antitumor capacity of NK cells. The invention also encompansses methods for use of NKG2D-DAP10-CD3 zeta polypeptides, vectors and cells in methods for treating cancer and other proliferative disorders, as well as infectious diseases.

Abstract: The invention provides a chimeric receptor comprising NKG2D, DAP10 and CD3 zeta. Also disclosed is a composition comprising this chimeric receptor and methods for making and using it to enhance the cytotoxicity and antitumor capacity of NK cells. The invention also encompasses methods for the use of NKG2D-DAP10-CD3 zeta polypeptides, vectors and cells in methods for treating cancer and other proliferative disorders, as well as infectious diseases.

Abstract: An antenna structure comprising a substrate and an antenna is provided. The substrate comprises an upper surface and an under surface. The antenna comprises a first metal pattern and a second metal pattern. The first metal pattern is disposed on the upper surface. The first metal pattern comprises a feeding portion and a transmission line connected to the feeding portion. The second metal pattern is disposed on the under surface, and comprises a first parasitic grounding arm, a second parasitic grounding arm, a connecting arm, a grounding plane and a grounding strip. The connecting arm has a parasitic slot, and connects the first parasitic grounding arm and the second parasitic grounding arm. The grounding strip connects the connecting arm and the grounding plane.